|About Clinical Trials|
|NCCTG Trial Listings|
|Institutional Members Only|
Updates on Restructuring of the National Cancer Clinical Trials System - 01/12/2011
This section provides information on National Cancer Institute (NCI) initiatives to restructure the National Cancer Clinical Trials System and updates on NCCTG initiatives to respond to these new directives and collaborate with the Cancer and Leukemia Group B (CALGB) and the American College of Surgeons Oncology Group (ACOSOG) to form a new cooperative group organization. Click here for more details
Mayo Clinic Researcher to Direct Major Cancer Statistical Center - 06/29/2010
ROCHESTER, Minn. — In a move that will improve efficiency and collaboration in cancer research, Mayo biostatistician Daniel Sargent, Ph.D., will become director of the Statistical Center for the Cancer and Leukemia Group B (CALGB), a national association of cancer researchers funded primarily by the National Cancer Institute (NCI).
Drug That Helps Metastatic Colon Cancer of No Benefit in Less Advanced Tumors. Mayo Clinic researchers say results are unexpected and puzzling - 06/07/2010
CHICAGO — To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer.
© Copyright 2014, NCCTG